Rasputin_Vol
"Slava Ukraina"
- Joined
- Aug 14, 2007
- Messages
- 71,963
- Likes
- 39,761
No matter who wins the election, I think Medicare will get the ability to negotiate drug prices. That will save the government some money but in the big picture, probably won't lower drug prices a lot.
The bigger leverage point in my opinion is importation of drugs. If that becomes legal, then the drug companies will have to price their drugs roughly the same across the developed countries.
It would kill Research within the large US pharma a but frankly, that is already happening. Japanese pharma companies are used to this environment and would probably do ok. The number of small biotechs would be reduced dramatically.
No matter who wins the election, I think Medicare will get the ability to negotiate drug prices. That will save the government some money but in the big picture, probably won't lower drug prices a lot.
The bigger leverage point in my opinion is importation of drugs. If that becomes legal, then the drug companies will have to price their drugs roughly the same across the developed countries.
The question then becomes how does new drug and tests be developed with profits to fund other new projects? The life span co ti he to increase which only add cost. There is no right answer. The cost of care is being is bei f shift to the individual with larger deductibles and copays
No doubt lower drug costs will lower research resulting in fewer branded drugs. Where is the tipping point? No one knows. There will still be incentives for breakthrough drugs but not for me too drugs. It is clear though that the current drug pricing system has very little public support.
Certain drug cost in the USA is ridiculous expensive compared to other nations. I take one drug that is approximately $350 for a 30 day supply in the USA, the same drug in Canada is $310-350 for 90 day supply with free shipping. There is zero reason an American Citizen should be paying triple what it cost in Canada.